SCHEMBL3679031

SCHEMBL3679031

O=C(O)[C@](O)(CO)N(O)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
ALOX5 P09917 2/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
HIF1A Q16665 1/20 0.39
ALDH1A1 P00352 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
HTT P42858 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 1/20 0.38
GLA P06280 1/20 0.38
PAX8 Q06710 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL421668 0.74 NPSR1 (0.39) NPC1RAB9ALMNASMN1; SMN2HIF1A
SCHEMBL6180241 0.74 NPSR1 (0.39) NPC1RAB9ALMNASMN1; SMN2HIF1A
SCHEMBL454800 0.72 SMN1; SMN2 (0.52) RIPK1ALOX5SMN1; SMN2HIF1AALDH1A1
SCHEMBL25291595 0.71 SMN1; SMN2 (0.42) RAB9ASMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL1938436 0.71 SMN1; SMN2 (0.42) RAB9ASMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7417637 0.70 KMT2A (0.44) NPC1RAB9ACA12CA9ALOX5
SCHEMBL28132469 0.69 SMN1; SMN2 (0.48) RIPK1ALOX5SMN1; SMN2HIF1AALDH1A1
Trifluoroacetic Acid SCHEMBL10698410 0.69 CYP2C19 (0.55) RIPK1NPC1RAB9ACA12CA9
SCHEMBL9872252 0.69 RIPK1 (0.50) RIPK1NPC1RAB9ACA12CA9
SCHEMBL31504509 0.69 NR1H2 (0.46) RIPK1NPC1RAB9ACA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044436-B1 METHODS AND COMPOSITIONS FOR DETECTION OF MICROORGANISMS AND CELLS AND TREATMENT OF DISEASES AND DISORDERS GENELUX CORP (US) 2014-06-04 EP disclosed
US-7820184-B2 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders GENELUX CORPORATION (US) 2010-10-26 US disclosed
US-7763420-B2 administering an Escherichia bacterium strain and detecting the bacterium to indicate the site of proliferation or proliferative conditions selected from tumors, injuries and inflammation GENELUX CORPORATION (US) 2010-07-27 US disclosed
US-20090180987-A1 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders GENELUX CORPORATION 2009-07-16 US disclosed
EP-2044436-A2 METHODS AND COMPOSITIONS FOR DETECTION OF MICROORGANISMS AND CELLS AND TREATMENT OF DISEASES AND DISORDERS Genelux Corporation (US) 2009-04-08 EP disclosed
US-20080193373-A1 administering an Escherichia bacterium strain and detecting the bacterium to indicate the site of proliferation or proliferative conditions selected from tumors, injuries and inflammation GENELUX CORPORATION 2008-08-14 US disclosed
WO-2008073148-A2 METHODS AND COMPOSITIONS FOR DETECTION OF MICROORGANISMS AND CELLS AND TREATMENT OF DISEASES AND DISORDERS GENELUX CORPORATION (US) 2008-06-19 WO disclosed